ERIC LOVATO: Open Payments
NPI 1194763342 · BANNING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,970 in 119 payments from 23 companies in 2025. Trend: 2023 $3,777 · 2024 $3,212 · 2025 $2,970
Food & beverage: $2,781Education: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $374 |
| LEO Pharma Inc. | 20 | $294 |
| Novartis Pharmaceuticals Corporation | 9 | $277 |
| Regeneron Healthcare Solutions, Inc. | 7 | $259 |
| Arcutis Biotherapeutics, Inc. | 6 | $219 |
| GENZYME CORPORATION | 5 | $193 |
| Organon LLC | 3 | $189 |
| JAZZ PHARMACEUTICALS INC. | 4 | $189 |
| Lilly USA, LLC | 3 | $151 |
| Incyte Corporation | 5 | $136 |
Products named: DUPIXENT, Zoryve, ADBRY, VTAMA, EPIDIOLEX, Rhapsido, SKYRIZI, BOTOX.
Industry payments across CA — which companies pay providers there.
